Abbott, Elan Drop Tricor IP Suits Against Biovail
Abbott Laboratories and Elan Corp. PLC continued Thursday to wrap up a campaign to block generic versions of the cholesterol drug Tricor, resolving lawsuits against Biovail Corp., which is now owned...To view the full article, register now.
Already a subscriber? Click here to view full article